Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,049 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $365.92 | 43 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $157.06 | 12 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $106.91 | 9 | $0 (2017) |
| Novo Nordisk Inc | $64.48 | 5 | $0 (2019) |
| Astellas Pharma US Inc | $57.11 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $44.03 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $40.02 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $32.69 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $25.09 | 2 | $0 (2022) |
| Circassia Pharmaceuticals Inc | $19.78 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $78.06 | 5 | Astellas Pharma US Inc ($28.20) |
| 2022 | $25.09 | 2 | GlaxoSmithKline, LLC. ($25.09) |
| 2020 | $11.28 | 1 | PFIZER INC. ($11.28) |
| 2019 | $146.21 | 9 | PFIZER INC. ($65.61) |
| 2018 | $306.30 | 25 | PFIZER INC. ($138.06) |
| 2017 | $482.30 | 50 | PFIZER INC. ($136.64) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Biological | ||||||
| 09/25/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes Care | ||||||
| 09/15/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Biological | ||||||
| 09/08/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/03/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: RESPIRATORY | ||||||
| 02/25/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/22/2019 | Antares Pharma, Inc. | Otrexup (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Rheumatoid Arthritis | ||||||
| 08/13/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Diabetes | ||||||
| 05/29/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: DIABETES | ||||||
| 05/09/2019 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2019 | Nalpropion Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: OBESITY | ||||||
| 02/27/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/25/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/18/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/12/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/12/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Obesity | ||||||
| 11/09/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/25/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/14/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/13/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/01/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,064 | 1,311 | $258,140 | $66,628 |
| 2022 | 21 | 1,175 | 1,606 | $250,985 | $65,989 |
| 2021 | 19 | 1,061 | 1,635 | $234,513 | $88,587 |
| 2020 | 17 | 998 | 1,484 | $152,332 | $65,256 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 352 | $89,056 | $14,498 | 16.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 276 | 276 | $54,648 | $11,752 | 21.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $16,443 | $8,175 | 49.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 81 | $13,932 | $4,933 | 35.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 56 | 56 | $7,378 | $4,245 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 90 | $16,020 | $3,423 | 21.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 25 | $12,200 | $3,338 | 27.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 34 | 49 | $6,909 | $3,031 | 43.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $5,130 | $2,716 | 52.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 25 | $6,675 | $2,506 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 42 | $14,868 | $2,260 | 15.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 30 | 30 | $8,820 | $1,832 | 20.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $1,728 | $1,693 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 77 | 108 | $2,592 | $1,028 | 39.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $945.00 | $899.64 | 95.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 17 | 17 | $306.00 | $209.95 | 68.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 14 | 14 | $490.00 | $87.20 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 342 | $86,526 | $13,782 | 15.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 285 | 285 | $56,430 | $12,205 | 21.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 24 | 24 | $12,089 | $6,679 | 55.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 95 | $16,340 | $5,251 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 87 | $15,486 | $3,251 | 21.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 21 | $10,248 | $3,235 | 31.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 37 | 37 | $3,959 | $2,599 | 65.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 35 | 35 | $2,730 | $2,369 | 86.8% |
About Dr. Stephen Cullen, MD
Dr. Stephen Cullen, MD is a Family Medicine healthcare provider based in Medina, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740250802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Cullen, MD has received a total of $1,049 in payments from pharmaceutical and medical device companies, with $78.06 received in 2023. These payments were reported across 92 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,049).
As a Medicare-enrolled provider, Cullen has provided services to 4,298 Medicare beneficiaries, totaling 6,036 services with total Medicare billing of $286,460. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Medina, OH
- Active Since 01/23/2006
- Last Updated 01/09/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1740250802
Products in Payments
- CHANTIX (Drug) $126.68
- LYRICA (Drug) $96.71
- ELIQUIS (Drug) $94.32
- FARXIGA (Drug) $65.60
- BEVESPI AEROSPHERE (Drug) $52.40
- TOUJEO (Drug) $44.03
- SPIRIVA (Drug) $40.43
- XARELTO (Drug) $40.02
- STIOLTO (Drug) $37.56
- JANUVIA (Drug) $32.69
- CONTRAVE (Drug) $30.11
- Myrbetriq (Drug) $28.91
- Veozah (Drug) $28.20
- Ozempic (Drug) $26.56
- TRELEGY ELLIPTA (Drug) $25.09
- SYMBICORT (Drug) $25.06
- Saxenda (Drug) $23.77
- TUDORZA PRESSAIR (Drug) $19.78
- Otrexup (Drug) $18.64
- NEXTSTELLIS (Drug) $18.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Medina
Dr. Lisa Esterle, D.o, D.O
Family Medicine — Payments: $11,624
Dr. Glenna Jackson, M.d, M.D
Family Medicine — Payments: $5,850
Dr. Andrew Chema, M.d, M.D
Family Medicine — Payments: $4,546
Catherine Taras, Md, MD
Family Medicine — Payments: $2,444
Luan Oconnor, Do, DO
Family Medicine — Payments: $1,792
Julie Reeves, Md, MD
Family Medicine — Payments: $1,748